Benefit OF using two different type of drugs during operation.

Not yet recruiting

• Conditions: Neoplasms,

• Registration Number: CTRI/2019/03/018028
• Lead Sponsor: Institute of Medical Sciences

Brief Summary

The study will be conducted in ,department of anaesthesiology,IMS ,BHU,VARANASI after written consent and institutional ethical approval.After CTRI registration ,80 patients of ASA grade I and II will be included.They will be randomly allocated to two groups of 40 patients each: DK (Dexmedetomidine & Ketamine) and DF (Dexmedetomidine & Fentanyl) groups. We will monitor extubation time ,recovery time,hemodynamic parameter (e.g.MAP,HR,SPO2 ,RR) and time for first analgesic requirements.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-20
• Last Update Posted: 2019-10-03

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

ASA GRADE I-II Major Surgeries.

Exclusion Criteria

1-Lack of patients consent 2-ASA Grade III-IV 3-Renal and Hepatic dysfunction 4-Respiratory disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recovery time,hemodynamic vital.	10,20 min of induction,every 15 min throughout procedure

Secondary Outcome Measures

Name	Time	Method
Time for first analgesic requirements,duration of PACU stay	2 hourly in postoperative period for 6 hours.

Trial Locations

Locations (1)

IMS; 🇮🇳 Varanasi, UTTAR PRADESH, India

IMS

🇮🇳Varanasi, UTTAR PRADESH, India

Mehershree

Principal investigator

9956867723

meherlodhi7@gmail.com